Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine

Overview

Journal Vaccines (Basel)

Date 2025 Jan 24

PMID 39852793

Authors

Hyein Jo

Jaewhoon Jeoung

Wonho Kim

Dooil Jeoung

Affiliations

Soon will be listed here.

Abstract

Messenger RNA (mRNA)-based therapeutics have shown remarkable progress in the treatment and prevention of diseases. Lipid nanoparticles (LNPs) have shown great successes in delivering mRNAs. After an mRNA-LNP vaccine enters a cell via an endosome, mRNA is translated into an antigen, which can activate adaptive immunity. mRNAs can bind to various pattern recognition receptors (PRRs), including toll-like receptors (TLRs), and increase the production of inflammatory cytokines. This review summarizes mechanisms of innate immunity induced by mRNAs. Polyethylene glycol (PEG) has been employed as a component of the mRNA-LNP vaccine. PEGylated nanoparticles display enhanced stability by preventing aggregation of particles. However, PEGylation can cause adverse reactions, including blood clearance (ABC) of nanoparticles via complement activation and anaphylaxis. Mechanisms of PEG-induced ABC phenomenon and anaphylaxis are presented and discussed. There have been studies aimed at reducing immune responses associated with PEG to make safe and effective vaccines. Effects of modifying or replacing PEG in reducing immune responses associated with PEGylated nanoparticles are also discussed. Modifying mRNA can induce immune tolerance, which can prevent hypersensitivity reactions induced by PEGylated mRNA-LNP vaccines. Current progress of immune tolerance induction in association with mRNA-LNP is also summarized. This review might be helpful for developing safe and effective PEGylated mRNA-LNP vaccines.

References

Liu M, Zhao D, Yan N, Li J, Zhang H, Liu M . Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions. Int J Pharm. 2021; 612:121365. DOI: 10.1016/j.ijpharm.2021.121365. View

Yang Q, Lai S . Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015; 7(5):655-77. PMC: 4515207. DOI: 10.1002/wnan.1339. View

West P, Bahri R, Garcia-Rodriguez K, Sweetland G, Wileman G, Shah R . Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins. Front Immunol. 2021; 11:615236. PMC: 7882629. DOI: 10.3389/fimmu.2020.615236. View

Jung S, Jeon J, Kim Y, Choe S, Lee S . Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study. Nat Commun. 2024; 15(1):6181. PMC: 11263712. DOI: 10.1038/s41467-024-50656-8. View

King H, Pokkali S, Kim D, Brammer D, Song K, McCarthy E . Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques. J Immunol. 2023; 211(11):1643-1655. PMC: 10656433. DOI: 10.4049/jimmunol.2300424. View

Bredholt G, Saevik M, Soyland H, Ueland T, Zhou F, Pathirana R . Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. Vaccine X. 2024; 20:100564. PMC: 11472110. DOI: 10.1016/j.jvacx.2024.100564. View

Xia J, Chen C, Dong M, Zhu Y, Wang A, Li S . Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance. J Control Release. 2023; 364:23-36. DOI: 10.1016/j.jconrel.2023.10.023. View

Mikhalkevich N, Russ E, Iordanskiy S . Cellular RNA and DNA sensing pathways are essential for the dose-dependent response of human monocytes to ionizing radiation. Front Immunol. 2023; 14:1235936. PMC: 10751912. DOI: 10.3389/fimmu.2023.1235936. View

Al Rahbani G, Woopen C, Dunsche M, Proschmann U, Ziemssen T, Akgun K . SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines (Basel). 2024; 12(6). PMC: 11209537. DOI: 10.3390/vaccines12060684. View

10.

Ju Y, Lee W, Pilkington E, Kelly H, Li S, Selva K . Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022; 16(8):11769-11780. DOI: 10.1021/acsnano.2c04543. View

11.

Munter R, Stavnsbjerg C, Christensen E, Thomsen M, Stensballe A, Hansen A . Unravelling Heterogeneities in Complement and Antibody Opsonization of Individual Liposomes as a Function of Surface Architecture. Small. 2022; 18(14):e2106529. DOI: 10.1002/smll.202106529. View

12.

Tahtinen S, Tong A, Himmels P, Oh J, Paler-Martinez A, Kim L . IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 2022; 23(4):532-542. DOI: 10.1038/s41590-022-01160-y. View

13.

Liccioli G, Mori F, Barni S, Pucci N, Novembre E . Anaphylaxis to Polyvinylpyrrolidone in Eye Drops Administered to an Adolescent. J Investig Allergol Clin Immunol. 2018; 28(4):263-265. DOI: 10.18176/jiaci.0252. View

14.

Ding Y, Chen Q, Xu H, Adi D, Ding Y, Luo W . siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice. J Lipid Res. 2024; 65(9):100626. PMC: 11418111. DOI: 10.1016/j.jlr.2024.100626. View

15.

Zhao M, Wan B, Li H, He J, Chen X, Wang L . Porcine 2', 5'-oligoadenylate synthetase 2 inhibits porcine reproductive and respiratory syndrome virus replication in vitro. Microb Pathog. 2017; 111:14-21. DOI: 10.1016/j.micpath.2017.08.011. View

16.

Xie Y, Chi Y, Tao X, Yu P, Liu Q, Zhang M . Rabies Virus Regulates Inflammatory Response in BV-2 Cells through Activation of Myd88 and NF-κB Signaling Pathways via TLR7. Int J Mol Sci. 2024; 25(17). PMC: 11395267. DOI: 10.3390/ijms25179144. View

17.

Zheng C, Zhang L . Identifying RNA Sensors in Antiviral Innate Immunity. Methods Mol Biol. 2024; 2854:107-115. DOI: 10.1007/978-1-0716-4108-8_12. View

18.

Khan A, Allemailem K, Almatroodi S, Almatroudi A, Rahmani A . Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications. 3 Biotech. 2020; 10(4):163. PMC: 7062946. DOI: 10.1007/s13205-020-2144-3. View

19.

Kos M, Bojarski K, Mertowska P, Mertowski S, Tomaka P, Dziki L . Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?. Cells. 2024; 13(20. PMC: 11506270. DOI: 10.3390/cells13201708. View

20.

Rohner E, Yang R, Foo K, Goedel A, Chien K . Unlocking the promise of mRNA therapeutics. Nat Biotechnol. 2022; 40(11):1586-1600. DOI: 10.1038/s41587-022-01491-z. View